1 Min Read
March 28 (Reuters) - Calithera Biosciences Inc:
* Calithera to receive $12 million milestone payment from Incyte for achievement of pharmacokinetic and pharmacodynamic goals in Phase 1 study Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.